Samuel Asare

Accra, Ghana – July 2025   The strategic partnership between AstraZeneca and Revna Biosciences is rapidly transforming the landscape of lung cancer care in Ghana. Since the initial announcement in April 2025, the collaboration has made remarkable progress in improving the…

Revna Biosciences is honored to announce that we’ve been recognized on Bloomberg’s inaugural “Africa Startups to Watch 2025” list—a testament to our commitment to innovation across Africa.  Bloomberg’s debut list shines a spotlight on African startups that are crafting inventive…

  AstraZeneca, a global biopharmaceutical company is in collaboration with Revna Biosciences, a precision medicine research and advanced diagnostics company to provide EGFR (Epidermal Growth Factor Receptor) biomarker testing in Ghana. This partnership goes beyond diagnostics and research, extending towards…